Insider Transactions in Q1 2022 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2022
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
11,517
-5.75%
|
$126,687
$11.27 P/Share
|
|
Mar 02
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
8,832
-6.87%
|
$97,152
$11.28 P/Share
|
|
Mar 02
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
29,588
-2.14%
|
$325,468
$11.15 P/Share
|
|
Mar 02
2022
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,974
-6.5%
|
$76,714
$11.19 P/Share
|
|
Mar 02
2022
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
12,060
-10.4%
|
$132,660
$11.09 P/Share
|
|
Mar 01
2022
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
4,084
-2.0%
|
$44,924
$11.19 P/Share
|
|
Mar 01
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
3,473
-2.63%
|
$38,203
$11.19 P/Share
|
|
Mar 01
2022
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
7,508
-0.54%
|
$82,588
$11.19 P/Share
|
|
Feb 28
2022
|
Gunther Birznieks SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+13.79%
|
-
|
|
Feb 28
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+19.85%
|
-
|
|
Feb 28
2022
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
115,000
+7.64%
|
-
|
|
Feb 28
2022
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+23.37%
|
-
|
|
Feb 28
2022
|
Timothy Williams SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+22.0%
|
-
|